Lv1
40 积分 2025-06-10 加入
Breaking the therapeutic ceiling in inflammatory bowel disease: myth or reality?
25天前
已完结
Comparative effectiveness research in inflammatory bowel disease: Real-world evidence for real world decisions
1个月前
已完结
A Comprehensive Literature Review and Expert Consensus Statement on Therapeutic Drug Monitoring of Biologics in Inflammatory Bowel Disease
1个月前
已完结
Drug development for ulcerative proctitis: current concepts
1个月前
已完结
Treatment sequencing in inflammatory bowel disease: Towards clinical precision medicine
1个月前
已完结
Therapeutic drug monitoring of biologics in inflammatory bowel disease: unmet needs and future perspectives
1个月前
已完结
A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial
1个月前
已完结
Vedolizumab in early and late Crohn's disease (LOVE-CD): a phase 4 open-label cohort study
1个月前
已完结
Efficacy and safety of mirikizumab in paediatric participants with moderately-to-severely active ulcerative colitis (SHINE-1): a multicentre, open-label, non-randomised phase 2 trial
5个月前
已完结
Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial
5个月前
已完结
皖公网安备34019202002308
